News


Resident News

ProteoFormiX Awarded € 265K VLAIO Research Grant

By JLABS

Read full story
Resident News

S-Biomedic is Gearing up for Significant Growth

By JLABS

Read full story
Resident News

AlphaBiomics wins award to validate its IBD biologic therapy response predictor RxSelex

By JLABS

Read full story
Other news

Knowledge for Growth 2018 Recap

By Janssen Belgium

Read full story
Other news

Want to know more about the JLABS Portfolio?

By JLABS

Read full story
Other news

IDEAYA Biosciences raised a $94M crossover Series B financing to develop next generation biomarker-enabled synthetic lethality therapies.

By Ideaya Biosciences

Read full story
Other news

Sirenas LLC. annouced today they have entered a muti-target research collaboration agreement with Bristol-Myers Squibb to deploy a drug discovery platform against undisclosed challenging therapeutic targets

By JLABS

Read full story
In the media

J&J extends its JLABS incubator scheme to Europe

By Phil Taylor

Read full story
In the media

Belgium chosen for first J&J ‘JLABS’ incubator in Europe

By Andrew McConaghie

Read full story
Other news

Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies

By JLABS

Read full story
Other news

Next stop, Europe! @JNJInnovation introduces @JLABS in Belgium

By JLABS

Read full story
In the media

Johnson & Johnson opens first European JLABS incubator

By Nick Paul Taylor

Read full story
Other news

Ensysce Biosciences has received Fast Track designation from the FDA for the development of abuse-resistant opioid drug PF614

By JLABS

Read full story
Other news

Arcturus Therapeutics expands collaboration with Takeda Pharmaceuticals

By JLABS

Read full story
Other news

Kara Bortone, Ph.D., Head of Johnson & JohnsonInnovation, JLABS in San Diego shares why her role is the coolest job in San Diego in San Diego Magazine

By JLABS

Read full story